Torsten Schröder

Institute for Systemic Inflammation Research (ISEF)
University of Lübeck

E-Mail: torsten.schroeder(at)uksh.de

Tel.: 0049 451 500 51405

 

Publications

1.1: Michaels MA, Jendrek ST, Korf T, Nitzsche T, Teegen B, Komorowski L, Derer S, Schröder T, Baer F, Lehnert H, Büning J, Fellerman K, Sina C. Pancreatic Autoantibodies Against CUZD1 and GP2 Are Associated with Distinct Clinical Phenotypes of Crohn's Disease. Inflamm Bowel Dis. 2015 Aug 13.PubMed PMID: 26273818.

2: Schröder T, Schmidt KJ, Olsen V, Möller S, Mackenroth T, Sina C, Lehnert H,Fellermann K, Büning J. Liver steatosis is a risk factor for hepatotoxicity inpatients with inflammatory bowel disease under immunosuppressive treatment. Eur J Gastroenterol Hepatol. 2015 Jun;27(6):698-704. PubMed PMID: 25923946.

3: Schröder T, Hubold C, Muck P, Lehnert H, Haas CS. A hypertensive emergency with acute visual impairment due to excessive liquorice consumption. Neth J Med. 2015 Feb;73(2):82-5. PubMed PMID: 25753073.

4. Bär F, Föh B, Pagel R, Schröder T, Schlichting H, Hirose M, Lemcke S, Klinger A, König P, Karsten CM, Büning J, Lehnert H, Fellermann K, Ibrahim SM, Sina C. Carboxypeptidase E modulates intestinal immune homeostasis and protects against experimental colitis in mice. PLoS One. 2014 Jul 22;9(7):e102347. PubMed PMID: 25051500.